324 related articles for article (PubMed ID: 16276355)
1. Metabotropic glutamate receptors in the basal ganglia motor circuit.
Conn PJ; Battaglia G; Marino MJ; Nicoletti F
Nat Rev Neurosci; 2005 Oct; 6(10):787-98. PubMed ID: 16276355
[TBL] [Abstract][Full Text] [Related]
2. Localization and physiological roles of metabotropic glutamate receptors in the direct and indirect pathways of the basal ganglia.
Marino MJ; Awad H; Poisik O; Wittmann M; Conn PJ
Amino Acids; 2002; 23(1-3):185-91. PubMed ID: 12373536
[TBL] [Abstract][Full Text] [Related]
3. Basal ganglia-thalamocortical circuits: their role in control of movements.
Alexander GE
J Clin Neurophysiol; 1994 Jul; 11(4):420-31. PubMed ID: 7962489
[TBL] [Abstract][Full Text] [Related]
4. GABAergic circuits in the basal ganglia and movement disorders.
Galvan A; Wichmann T
Prog Brain Res; 2007; 160():287-312. PubMed ID: 17499121
[TBL] [Abstract][Full Text] [Related]
5. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies.
Middleton FA; Strick PL
Brain Cogn; 2000 Mar; 42(2):183-200. PubMed ID: 10744919
[TBL] [Abstract][Full Text] [Related]
6. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
[TBL] [Abstract][Full Text] [Related]
7. Role of metabotropic glutamate receptors in animal models of Parkinson's disease.
Senkowska A; Ossowska K
Pol J Pharmacol; 2003; 55(6):935-50. PubMed ID: 14730087
[TBL] [Abstract][Full Text] [Related]
8. Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders.
Rouse ST; Marino MJ; Bradley SR; Awad H; Wittmann M; Conn PJ
Pharmacol Ther; 2000 Dec; 88(3):427-35. PubMed ID: 11337032
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids and basal ganglia functionality.
Fernández-Ruiz J; Lastres-Becker I; Cabranes A; González S; Ramos JA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):257-67. PubMed ID: 12052041
[TBL] [Abstract][Full Text] [Related]
10. Brainstem interactions with the basal ganglia.
Redgrave P; Coizet V
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S301-5. PubMed ID: 18267254
[TBL] [Abstract][Full Text] [Related]
11. Glutamate-dopamine-GABA interactions in the aging basal ganglia.
Mora F; Segovia G; Del Arco A
Brain Res Rev; 2008 Aug; 58(2):340-53. PubMed ID: 18036669
[TBL] [Abstract][Full Text] [Related]
12. [Functional analysis of the roles of direct and indirect pathways by using immunotoxin-mediated cell targeting approach].
Fukabori R; Kobayashi K
Brain Nerve; 2009 Apr; 61(4):412-8. PubMed ID: 19378811
[TBL] [Abstract][Full Text] [Related]
13. Roles of the thalamic CM-PF complex-Basal ganglia circuit in externally driven rebias of action.
Minamimoto T; Hori Y; Kimura M
Brain Res Bull; 2009 Feb; 78(2-3):75-9. PubMed ID: 18793702
[TBL] [Abstract][Full Text] [Related]
14. Role of basal ganglia-brainstem pathways in the control of motor behaviors.
Takakusaki K; Saitoh K; Harada H; Kashiwayanagi M
Neurosci Res; 2004 Oct; 50(2):137-51. PubMed ID: 15380321
[TBL] [Abstract][Full Text] [Related]
15. Pathways for control of face and neck musculature by the basal ganglia and cerebellum.
Pong M; Horn KM; Gibson AR
Brain Res Rev; 2008 Aug; 58(2):249-64. PubMed ID: 18199482
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the basal ganglia by metabotropic glutamate receptors: potential for novel therapeutics.
Marino MJ; Conn PJ
Curr Drug Targets CNS Neurol Disord; 2002 Jun; 1(3):239-50. PubMed ID: 12769617
[TBL] [Abstract][Full Text] [Related]
17. Physiology and pathophysiology of the basal ganglia-thalamo-cortical networks.
Rosin B; Nevet A; Elias S; Rivlin-Etzion M; Israel Z; Bergman H
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S437-9. PubMed ID: 18267279
[TBL] [Abstract][Full Text] [Related]
18. Modeling the functional organization of the basal ganglia. A parallel distributed processing approach.
Mitchell IJ; Brotchie JM; Brown GD; Crossman AR
Mov Disord; 1991; 6(3):189-204. PubMed ID: 1922123
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
[TBL] [Abstract][Full Text] [Related]
20. Circuits and circuit disorders of the basal ganglia.
DeLong MR; Wichmann T
Arch Neurol; 2007 Jan; 64(1):20-4. PubMed ID: 17210805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
